SpringerLink
Log in

Adjuvant oral Razoxane (ICRF 159) in resectable colo-rectal cancer

  • Letter to the Editor
  • Razoxase Colo-Rectal Cancer
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Gilbert JM (1982) Adjuvant chemotherapy of large-bowel cancer. Cancer Treat Rev 9:195–228

    Google Scholar 

  2. Gilbert JM, Hellmann K, Evans M, Cassell PG, Stoodley B, Ellis H, Wastell C (1982) Adjuvant Razoxane (ICRF 159) in resectable colo-rectal cancer. Cancer Chemother Pharmacol 8:293–299

    Google Scholar 

  3. Gill PG, Morris PJ (1978) The survival of patients with colo-rectal cancer treated in a regional hospital. Br J Surg 65:17–20

    Google Scholar 

References

  1. Peto R, Pike MC, Armitage P et al. (1976) Design and analysis of randomised clinical trials requiring prolonged observation of each patient. Br J Cancer 34:585–612; (1977) Br J Cancer 35:1–39

    Google Scholar 

Download references

Authors
  1. M. L. Slevin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. J. Harvey
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. F. M. Wrigley
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. M. Gilbert
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K. Hellmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Evans
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. P. G. Cassell
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. B. Stoodley
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. H. Ellis
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. C. Wastell
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Slevin, M.L., Harvey, V.J., Wrigley, P.F.M. et al. Adjuvant oral Razoxane (ICRF 159) in resectable colo-rectal cancer. Cancer Chemother. Pharmacol. 10, 228–229 (1983). https://doi.org/10.1007/BF00255772

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00255772

Keywords

Search

Navigation